PR Newswire: news distribution, targeting and monitoring
2014

Mendor Announces Partnership with A. Menarini Diagnostics for European-wide Distribution of its All-in-one Blood Glucose Monitoring System

Share with Twitter Share with LinkedIn

ESPOO, Finland, May 27, 2013 /PRNewswire/ --



Mendor, the Finnish diabetes technology company, is proud to announce its partnership with A. Menarini Diagnostics S.r.l, one of Europe's leading diagnostics companies in the field of diabetes. The agreement will bring Mendor's all-in-one blood glucose monitoring system to nine new European markets in the first stage as a part of Menarini's established GlucoMen product family for glucose testing.

A. Menarini Diagnostics S.r.l was founded in 1976 and today has a European-wide organisation with a headquarters based in Florence and a network of fourteen fully owned affiliates. Its 2012 turnover was approximately 300 million Euro.

A. Menarini Diagnostics has more than 35 years of experience in blood glucose monitoring sales and marketing in European markets providing Mendor with an experienced and successful partner in its commercial expansion in the EU area. Menarini Diagnostics are renowned for offering cutting edge, high quality products, dedicated to exceeding the needs of healthcare professionals and to enhancing the quality of life of patients - the same values that have driven the development of Mendor's products. The first launches of this BGT system are scheduled in the near future in key European markets.

Mendor's all-in-one blood glucose monitoring system is a unique device that contains all the necessary components for daily blood glucose measurements: a meter, 25 strips and a lancing device in an integrated, stylish device the size of a mobile phone. It is designed to simplify the lives of people with diabetes who need to test their blood glucose levels regularly. The device will be launched under the name of GlucoMen READY.  

Through this new partnership Mendor hopes to ensure its continued growth and expansion within important European markets and facilitate on-going negotiations in new territories with key companies in the global diabetes market like Menarini. The partnership complements Mendor's previous distribution agreements with Merck Serono Ltd. in the UK, Mediq in the Baltics, and continues the already mutually rewarding partnership with A. Menarini Diagnostics Nordics in Sweden.

Mendor's CEO Kristian Ranta comments: "We are thrilled to have such a great partnership in place with a true frontrunner in diabetes care - Menarini. We are delighted to have such a strong partner in Europe to take our product out to key markets and feel proud to have gained such an important partnership to reward our development efforts. We are looking forward to building a better future for people with diabetes together with solid partners such as Menarini."

The General Manager of A. Menarini Diagnostics S.r.l., Dr. Crescenzio Izzo, added: "We are satisfied to have signed this agreement with such a young and innovative company as Mendor. This all-in-one system shall go towards completing our current Home Glucose testing product portfolio and allow us to offer diabetic patients a meter which is not only an attractive in design but also clinically proven, high quality and, above all, discreet."

About Menarini

Menarini, headquarters of the Menarini Group, was founded in Naples in 1886 and then moved to Florence in 1915. Today it is the leading Italian pharmaceutical company in the world, ranking 17th in Europe and 34th in the world (IMS World Review 2012). Present in over 100 countries throughout the world, today it counts 16,640 employees and has a 2012 turnover of over €3 billion. Research and internationalisation represent the main areas of strategic development for its future.  

The Group has 14 manufacturing sites located in Italy and abroad where over 545 million packages/year are produced and distributed throughout five continents, thus allowing Menarini to contribute to the health of patients all over the world with its high quality standards.

For further information please see our website:  http://www.menarini.com.

Images available on request. For more information, visit: http://www.mendor.com

Technical information:

Mendor Discreet™/Glucomen READY is a CE marked IVD medical device. It is an all-in-one type premium class portable blood glucose monitoring device. The product has a modern design outlook, high quality features, materials and product finishing. The device contains all required functions in one device; test strip dispensing system, lancing device and measuring electronics. The device has been designed for people with diabetes who need to measure their blood glucose values as a part of their treatment.

Media Contact:
Sanna Usva - Mgmt Assistant
Tel: +358-9-315-77-300
E-mail: info@mendor.com

SOURCE Mendor



Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn
 

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

 
 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

 
 

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

 

Online Member Center

Not a Member?
Click Here to Join
Login
Search News Releases
Advanced Search
Search
  1. PR Newswire Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
  5. Send a News Release